Archives
-
AO/PI Double Staining Kit: Practical Guide
2026-09-16
The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for separating viable, apoptotic, and necrotic populations using Acridine Orange and Propidium Iodide. It is suitable for research cell viability assays and preliminary apoptosis or necrosis detection, but it should not be treated as a standalone diagnostic or definitive pathway assay.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-15
Track mRNA entry with Cy5 while measuring productive translation through firefly luciferase in the same experiment. This practical workflow connects delivery optimization, immune-aware assay design, and in vivo bioluminescence imaging without confusing cellular uptake with functional expression.
-
Maridomycin: In Vitro and In Vivo Activity
2026-09-15
The reference study established a broad antibacterial profile for maridomycin by combining susceptibility testing, resistance selection, bactericidal analysis, serum-binding measurements, and mouse infection experiments. Its findings show strong activity against many Gram-positive organisms, selective activity against some Gram-negative bacteria, macrolide-associated cross-resistance, and therapeutic effects in experimental infections.
-
Fulvestrant (ICI 182,780) Experimental Workflows
2026-09-14
Build reproducible ER-antagonism studies with Fulvestrant (ICI 182,780), from dose-response experiments in MCF7 and T47D cells to chemotherapy-sensitization and mechanistic validation. The workflow connects ERα depletion, MDM2 protein degradation, apoptosis, and carefully bounded immune-stress assays without overstating what cross-domain evidence can prove.
-
Gastric Cancer Assembloids Model Tumor–Stroma Complexity
2026-09-14
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell subpopulations from the same tissue. The model reproduced clinically relevant tumor–stroma interactions, altered transcriptional programs, and patient- and drug-specific response patterns that were not apparent in tumor-only organoids.
-
BMS-777607: A Mechanistic Assay Guide
2026-09-13
BMS-777607 is a selective c-Met inhibitor for resolving MET-family signaling in cancer and stem-cell assays. This guide connects its biochemical profile with an optimized iPSC-derived platelet study while emphasizing controls, assay maturity, and interpretation limits.
-
Wallichinine Reverses ABCB1-Mediated MDR
2026-09-12
The 2016 study by Lv and colleagues identifies wallichinine as a natural-product inhibitor of ABCB1-mediated multidrug resistance, showing that it restores the activity of vincristine and doxorubicin in ABCB1-overexpressing cancer cells. Its combined cytotoxicity, drug-transport, ATPase, and modeling experiments provide a mechanistic framework for evaluating ABCB1 reversal agents while highlighting the limits of metabolic viability readouts alone.
-
Acetoacetic Acid Sodium Salt Workflows
2026-09-11
Build reproducible ketone-body experiments with a water-soluble sodium acetoacetate format, practical dosing guidance, and controls for diabetes and energy metabolism models. A deuterium-labeling study adds an analytical lesson: rigorous standardization and orthogonal verification can make metabolic measurements more defensible.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-11
Use one transcript to separate cellular delivery from productive translation: Cy5 reveals where mRNA travels, while Firefly Luciferase reports functional protein expression. This workflow shows how to optimize transfection, compare lipid nanoparticles, and troubleshoot intracellular trafficking with quantitative fluorescence and bioluminescence readouts.
-
Cichoric Acid, HIF-1α, and Septic AKI
2026-09-10
The reference study identifies a metabolic–inflammatory mechanism linking M1 macrophage polarization, succinate dehydrogenase activity, HIF-1α-driven glycolysis, and NLRP3 activation in sepsis-induced acute kidney injury. Its integrated cell and mouse experiments show that cichoric acid protects renal tissue while providing a framework for evaluating immunometabolic interventions.
-
Bobcat339: TET Inhibition for DNA Methylation Studies
2026-09-10
Bobcat339 is a cytosine structure-based TET enzyme inhibitor for separating TET1/TET2-dependent DNA demethylation from UHRF1-driven methylation biology. This workflow connects biochemical inhibition with methylation, super-enhancer, transcriptional, autophagy, and osteogenic readouts while emphasizing dose validation and mechanism-specific controls.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Assays
2026-09-09
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, separates mRNA uptake from functional translation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers controls, handling, interpretation, vendor selection, and translational relevance.
-
Matrine: Mechanisms, Evidence, and Protocols
2026-09-09
Matrine is a Sophora-derived quinolizidine alkaloid with preclinical anticancer and anti-inflammatory activity. Evidence supports apoptosis induction, ROS generation, and signaling changes, but thymoma mechanisms remain hypothesis-generating rather than clinically validated.
-
Bleomycin Sulfate: From Damage to Translation
2026-09-08
Bleomycin Sulfate is more than a cytotoxic reagent: it is a mechanistic bridge between DNA damage, cancer response, and pulmonary fibrosis research. This thought-leadership guide shows how translational teams can move beyond single-point viability assays toward time-resolved, interpretable models.
-
Phosphatase Inhibitor Cocktail 1 Workflow
2026-09-08
Protect labile phosphorylation signals from harvest through analysis with a practical 100X DMSO-based workflow. This guide connects phosphatase control to YAP/Hippo pathway research, phosphoproteomics, immunoprecipitation, and troubleshooting decisions that improve interpretability.